Sorafenib-Induced Interstitial Pneumonitis in a Patient with Hepatocellular Carcinoma: A Case Report

Sorafenib is an oral multikinase inhibitor that has shown a survival benefit in patients with advanced hepatocellular carcinoma, and is considered to be generally safe. We treated a patient with interstitial lung disease that was associated with sorafenib therapy for the treatment of advanced hepato...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Myung, Hyung-Joon, Jeong, Sook-Hyang, Kim, Jin-Wook, Kim, Hee-Sup, Jang, Je-Hyuck, Yoon, Ho Il, Kim, Jae-Sung
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: The Korean Society of Gastroenterology; the Korean Society of Gastrointestinal Endoscopy; the Korean Association for the Study of the Liver; the Korean Society of Neurogastroenterology and Motility; Korean Association for the Study of Intestinal Diseases; Korean College of Helicobacter and Upper Gastrointestinal Research; Korean Society of Pancreatobiliary Diseases 2010
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3021613/
https://ncbi.nlm.nih.gov/pubmed/21253306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl.2010.4.4.543
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller